Company Legal Name
Latest Valuation
Founded Year
Headquarters
Medra operates an automation system that leverages artificial intelligence and robotics to execute and optimize biotech laboratory experiments. Based in San Francisco, the company addresses critical inefficiencies in pharmaceutical and biotechnology research by replacing manual, time-intensive laboratory processes with intelligent automated workflows. Medra's platform enables biotech companies to accelerate drug discovery timelines while reducing human error and operational costs. The system continuously learns and refines experimental protocols, potentially transforming how life sciences organizations conduct research and development. The company is currently focused on scaling its AI-driven laboratory automation technology to serve the growing demand for faster, more reliable biotech experimentation across the industry.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
